Health Condition 1: H712- Cholesteatoma of mastoid Health Condition 2: H701- Chronic mastoiditis
Conditions
Interventions
Intervention1: Sugammadex: I will compare the effect Sugammadex (2mg/kg) with Neostigmine (0.5 mg/kg) on resoiratory muscle strength in post extubation period and 30 minutes after shifting in PACU
Co
Sponsors
ESIC Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: American Society of Anaesthesiologist (ASA) physical status 1 and 2 posted for surgery under general anaesthesia
Exclusion criteria
Exclusion criteria: Parturient or lactating women OR undergoing thoracic or abdominal surgery OR neuromuscular disease chronic obstructive pulmonary disease significant kidney and liver disease OR allergic to rocuronium neostigmine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate and compare the effect of sugammadex and neostigmine on difference in thickening fraction of internal oblique (TFIO) from baseline to TOFR more than or equal to 0.9Timepoint: preoperative and in Post extubation at TOFR more than or equal to 0.9 | — |
Secondary
| Measure | Time frame |
|---|---|
| compare change in TFIO and diaphragm excursion from baseline to 30 minutes in PACU in both groupsTimepoint: 30 minutes in PACU | — |
Countries
India
Contacts
Public ContactDR Sonia Saini
ESIC Medical College and Hospital
Outcome results
None listed